Skip to main content
AmigoFish

Rumors of biggest pharma merger ever drop amid Q2 earnings, contentious FDA adcomms

From BioSpace · · 23 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

The industry has been abuzz since the weekend when talks of a potential mega-merger between Bristol Myers Squibb and AstraZeneca were reported. Meanwhile, Pfizer, Merck and others release second quarter earnings, with some disclosing pipeline discontinuations and cost-cutting measures. Finally, all eyes turn to the FDA in the wake of heated advisory committee meetings for Capricor Therapeutics and Replimune.

Back to BioSpace · Report a problem